Giving in the time of COVID-19: A conversation with Victoria Vrana about the new PowerOf platform

Fund Health Illustration

Read next

Researcher examining lab work

“We’re preparing for 2021 today”: An update on the Therapeutics Accelerator

Trevor Mundel provides an update on the COVID-19 Therapeutics Accelerator's progress in research, manufacturing, and testing. Mundel leads the foundation's efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.
Trevor Mundel President, Global Health, Bill & Melinda Gates Foundation
Researcher examining lab work

A COVID-19 vaccine might be ready within 18 months. But what happens then?

Developing and manufacturing a vaccine against COVID-19 is only part of the solution. Coordination, political will, and the infrastructure to support equitable vaccine is distribution will be essential to the ongoing COVID-19 response.
Mark Suzman with scientists in lab

Our COVID-19 response: Q&A with Mark Suzman

On Friday, April 17, Mark Suzman, CEO of the Gates Foundation, joined a conference call with The Optimist subscribers to discuss the foundation's response to the COVID-19 pandemic. Listen to the recording of the call here.
By Mark Suzman CEO, Board Member, Bill & Melinda Gates Foundation